Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04344938
Recruitment Status : Not yet recruiting
First Posted : April 14, 2020
Last Update Posted : April 17, 2020
Sponsor:
Collaborator:
Doaa M.EL Shehaby
Information provided by (Responsible Party):
Noha Esmael Ebrahem, Assiut University

Brief Summary:
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work not withstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?

Condition or disease Intervention/treatment
Covid 19 Pandemic From Ethical View Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality

Layout table for study information
Study Type : Observational
Estimated Enrollment : 874 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality
Estimated Study Start Date : April 2020
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : July 2020

Group/Cohort Intervention/treatment
medical personel Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work notwithstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?

non medical personel Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work notwithstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?




Primary Outcome Measures :
  1. Evaluate the ethical requirement of controlled disrupts of patients In case of infectious disease pandemic [ Time Frame: 2 months ]
    questionaire done to To keep the general preventive measure in the community



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
medical and non medical personel
Criteria

Inclusion Criteria:

  • adult aged 18 years to 60 years
  • medical personel graduated from egyptian faculty of medicine.
  • non medical personel live in egypt

Exclusion Criteria:

  • personel less than 18 years old .
  • medical personel not graduated from egyptian faculty of medicine.
  • non medical personel live outside egypt
Layout table for additonal information
Responsible Party: Noha Esmael Ebrahem, lecturer of forensic medicine and clinical toxicology, Assiut University
ClinicalTrials.gov Identifier: NCT04344938    
Other Study ID Numbers: 2020A10
First Posted: April 14, 2020    Key Record Dates
Last Update Posted: April 17, 2020
Last Verified: April 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No